92 related articles for article (PubMed ID: 22517713)
1. Prognostic value of survivin expression in Wilms tumor.
Basta-Jovanovic G; Radojevic-Skodric S; Brasanac D; Djuricic S; Milasin J; Bogdanovic L; Opric D; Savin M; Baralic I; Jovanovic M
J BUON; 2012; 17(1):168-73. PubMed ID: 22517713
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
[TBL] [Abstract][Full Text] [Related]
4. The expression of HSP70 and HSP90alpha in children with Wilms tumor.
Yang Y; Niu ZB; Hou Y; Wang CL
J Pediatr Surg; 2006 Jun; 41(6):1062-6. PubMed ID: 16769335
[TBL] [Abstract][Full Text] [Related]
5. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
6. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
7. p53 immunopositivity in histologically favorable Wilms tumor is not related to stage at presentation or to biological aggression.
D'Angelo MF; Kausik SJ; Sebo TJ; Rathbun SR; Kramer SA; Husmann DA
J Urol; 2003 May; 169(5):1815-7. PubMed ID: 12686851
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
9. Survivin gene promoter -31 G/C polymorphism is associated with Wilms tumor susceptibility in Serbian children.
Radojevic-Skodric S; Basta-Jovanovic G; Brasanac D; Nikolic N; Bogdanovic L; Milicic B; Milasin J
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e310-4. PubMed ID: 22858571
[TBL] [Abstract][Full Text] [Related]
10. Correlation between survivin expression and prognosis in non-small cell lung cancer.
Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
[TBL] [Abstract][Full Text] [Related]
11. PAX2 expression in Wilms tumors and other childhood neoplasms.
Davis JL; Matsumura L; Weeks DA; Troxell ML
Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
[TBL] [Abstract][Full Text] [Related]
12. The survivin:fas ratio in pediatric renal tumors.
Takamizawa S; Scott D; Wen J; Grundy P; Bishop W; Kimura K; Sandler A
J Pediatr Surg; 2001 Jan; 36(1):37-42. PubMed ID: 11150435
[TBL] [Abstract][Full Text] [Related]
13. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
16. A 23-year experience with malignant renal tumors in infancy and childhood.
Tröbs RB; Hänsel M; Friedrich T; Bennek J
Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
[TBL] [Abstract][Full Text] [Related]
17. [Expression of Stat3, HIF-1alpha and VEGF in Wilms' tumor].
Niu ZB; Wang CL; Hou Y; Yang Y; Gao H
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):461-4. PubMed ID: 17937859
[TBL] [Abstract][Full Text] [Related]
18. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.
Sehic D; Karlsson J; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2012 Jul; 59(1):62-8. PubMed ID: 22180226
[TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour.
Maschietto M; Piccoli FS; Costa CM; Camargo LP; Neves JI; Grundy PE; Brentani H; Soares FA; Camargo Bd; Carraro DM
Eur J Cancer; 2011 Dec; 47(18):2715-22. PubMed ID: 21703850
[TBL] [Abstract][Full Text] [Related]
20. Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.
Camassei FD; Arancia G; Cianfriglia M; Bosman C; Francalanci P; Ravà L; Jenkner A; Donfrancesco A; Boldrini R
Am J Clin Pathol; 2002 Mar; 117(3):484-90. PubMed ID: 11888090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
